About F.MED
F.MED is a company based in Fukuoka (Japan) founded in 2021 by Susumu Oguri. F.MED has raised $4 million across 2 funding rounds from investors including FFG Venture Business Partners, GxPartners and Astem. F.MED operates in a competitive market with competitors including MicroSure, AcuSurgical, Dishi Medical, Hunan Zhuo Shi Chuangsi Technology and Mynutia, among others.
- Headquarter Fukuoka, Japan
- Founders Susumu Oguri
- SectorsHealthcare
- Website f-med.co.jp
- Total Equity Funding$4M (USD)
in 2 rounds
- Latest Funding Round$2.67M (USD), Series A
Jul 2024
- InvestorsFFG Venture Business Partners
& 8 more
Funding Insights of F.MED
F.MED has successfully raised a total of $4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.67 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4M
- Total Rounds 2
- Last Round Series A — $2.67M
- First Round $1.33M
(Dec 2022)
- Investors Count 9
All 2 funding rounds of F.MED with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $2.67M | Series A | – | – | |
| Dec 2022 | $1.33M | Seed | – | – |
9 investors in total: 9 institutional.
Investors in F.MED
F.MED has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include FFG Venture Business Partners, GxPartners and Astem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | ffg-venture.co.jp | - | |
GxPartners is engaged in venture capital for seed and early-stage startups. | – | gxpartners.vc | Fukuoka, Japan | |
Investment support is provided to growing companies and sectors. | – | oita-vc.co.jp | Oita, Japan | |
Venture capital investments are made in research-driven startups. | 2014 | miraisozo.co.jp | Tokyo, Japan | |
- | – | higincapital.co.jp | - | |
- | – | mucap.co.jp | - | |
- | – | diamondmedino.com | - | |
- | – | jmtc.co.jp | - | |
Astem is engaged in developing advanced medical technology devices. | – | astem-jp.com | Kawasaki, Japan |
Investor details for F.MED
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of F.MED
1 people are tracked at F.MED (1 in leadership).
| Name | Role | Group |
|---|---|---|
Susumu Oguri | Co-Founder | Leadership |
Complete people profiles for F.MED
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of F.MED
3 dated milestones of F.MED across 3 years, from founding to its latest funding, stage changes and deals.
- Founded F.MED is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Series A, of $2.7M.
Competitors of F.MED
F.MED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MicroSure, AcuSurgical, Dishi Medical, Hunan Zhuo Shi Chuangsi Technology and Mynutia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| microsure.nl | 2014 | Eindhoven, Netherlands | $43.05M | – | Developer of robotic solutions to advance microsurgery | |
| acusurgical.com | 2017 | Montpellier, France | $6.88M | – | Provider of robotic technologies for retinal micro-surgery | |
| dessight.cn | 2021 | Hangzhou, China | $695,097 | – | Surgical robots for ophthalmic retinal procedures are developed. | |
| durofi.com | 2021 | Changsha, China | – | – | Brain rapid laser positioning systems for neurosurgical procedures are provided. | |
| mynutia.com | 2017 | Leuven, Belgium | – | – | Develops robotic systems for stabilizing eye surgery instruments and improving precision. |
Detailed competitors of F.MED
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of F.MED
The website of F.MED (f-med.co.jp) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 11.5% vs previous month
Latest news on F.Med
Complete news archive for F.MED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to F.MED
10 companies that operate in the same segment as F.MED (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about F.MED
F.MED was founded in 2021 and raised its 1st funding round 1 year after it was founded.
F.MED is headquartered in Fukuoka, Japan. It is registered at Fukuoka, Fukuoka, Japan.
F.MED is a funded company, having raised a total of $4M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.33M, raised on Dec 2022.
F.MED was founded in 2021 in Fukuoka, Japan, within the medical robotics sector. Robotic manipulator systems are developed to support microsurgery by handling surgical tools and enhancing the surgical environment. Operations center on creating assistive technologies that improve precision in procedures. The focus remains on innovation for healthcare applications in the region.
F.MED's top competitors include Dishi Medical, MicroSure and AcuSurgical.
F.MED has 9 investors. Key investors include FFG Venture Business Partners, GxPartners, Astem, Oita Venture Capital, and Mirai Sozo Investments.